Evaluation of prospective real-time quantitative PCR monitoring for minimal residual disease to predict relapse and direct molecularly targeted therapy with arsenic trioxide in acute promyelocytic leukaemia: analysis of 407 patients, including results of the MRC AML15 trial

D Grimwade, J V Jovanovic, R K Hills, E A Nugent, Y Patel, R Flora, D Diverio, K Jones, H Aslett, E Batson, R E Clark, E Solomon, F Lo Coco, K Wheatley, A K Burnett

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)162
Number of pages1
JournalBritish Journal of Haematology
Publication statusPublished - 2008
Event48th Annual Scientific Meeting of the British-Society-for-Haematology - Glasgow, SCOTLAND
Duration: 1 Jan 2008 → …

Cite this